Research Overview: Tirzepatide
Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, representing an advanced class of incretin-based therapeutic compounds. This 39-amino acid peptide demonstrates unique pharmacological properties through its ability to simultaneously activate both GIP and GLP-1 receptor pathways. Researchers at Stroid UK Shop can access this laboratory-grade compound from Hubio Pharm for in-vitro metabolic studies. The compound exhibits exceptional binding affinity for both target receptors, making it valuable for investigating dual incretin pathway modulation in cellular and tissue-based research models.
Laboratory Applications
Tirzepatide serves as a critical research tool for studying glucose homeostasis, insulin sensitivity, and metabolic regulation pathways. Scientists examine its effects on pancreatic beta-cell function, hepatic glucose production, and adipose tissue metabolism in controlled laboratory environments. The compound’s dual receptor activity provides unique insights into incretin biology that cannot be achieved with single-pathway modulators. Researchers investigating fat burner compounds utilise tirzepatide to understand appetite regulation mechanisms and energy expenditure modulation. The peptide’s stability profile and receptor selectivity make it particularly suitable for extended cell culture studies examining metabolic signalling cascades. Comparative studies with other research compounds from our SARMs collection and peptides range provide comprehensive metabolic research capabilities.
Specifications
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
|---|---|
| Molecular Weight | 4813.5 g/mol |
| CAS Number | 2023788-19-2 |
| Purity | ≥98% (HPLC verified) |
| Format | Lyophilised powder |
| Vial Size | 10mg per vial |
| Storage | -20°C, protect from light |
| Solubility | Water, sterile saline |
Research Compliance
This tirzepatide preparation is manufactured by Hubio Pharm exclusively for laboratory research applications. The compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must follow appropriate safety protocols and institutional guidelines when handling this material. All studies should be conducted by qualified personnel in properly equipped laboratory facilities with appropriate waste disposal procedures.
